Both in the context of exclusively dietary interventions and after bariatric surgery or treatment with GLP(glucagon-like peptide)-1 analogs, there is not only a reduction in weight, but also a loss of muscle mass to varying degrees. A differentiated clinical examination shows that this loss does not necessarily equate to a functional deterioration.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- HAUSARZT PRAXIS
Related Topics
You May Also Like
- Diabetic ketoacidosis
Recommendations for action in practice
- Migraine: better quality of life thanks to multimodal care
Broader selection of innovative migraine prophylactics and acute therapies
- Therapy of non-tumor-related pain
Do not prescribe opioids lightly for musculoskeletal pain
- Migraine
Fremanezumab for comorbid migraine and depression
- Case study
Moyamoya disease in a 23-year-old female patient
- Dapagliflozin for T2D and heart failure
Epicardial fat reduced in patients with type 2 diabetes and HF
- A hub of biological aging
Mitochondrial dysfunction and energy metabolism
- Health Literacy